An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder
Clinical trial NCT02473289 · COMPLETED
Trial details
- NCT number
- NCT02473289
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-23
- Primary completion
- 2018-05-22
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.